Field of the Invention
Certain embodiments disclosed herein relate generally to prostheses for implantation within a lumen or body cavity. In particular, certain embodiments relate to expandable prostheses such as replacement heart valves, such as for the mitral valve, that are configured to atraumatically grasp intralumenal tissue.
Description of the Related Art
Human heart valves, which include the aortic, pulmonary, mitral and tricuspid valves, function essentially as one-way valves operating in synchronization with the pumping heart. The valves allow blood to flow downstream, but block blood from flowing upstream. Diseased heart valves exhibit impairments such as narrowing of the valve or regurgitation, which inhibit the valves' ability to control blood flow. Such impairments reduce the heart's blood-pumping efficiency and can be a debilitating and life threatening condition. For example, valve insufficiency can lead to conditions such as heart hypertrophy and dilation of the ventricle. Thus, extensive efforts have been made to develop methods and apparatuses to repair or replace impaired heart valves.
Prostheses exist to correct problems associated with impaired heart valves. For example, mechanical and tissue-based heart valve prostheses can be used to replace impaired native heart valves. More recently, substantial effort has been dedicated to developing replacement heart valves, particularly tissue-based replacement heart valves that can be delivered with less trauma to the patient than through open heart surgery. Replacement valves are being designed to be delivered through minimally invasive procedures and even percutaneous procedures. Such replacement valves often include a tissue-based valve body that is connected to an expandable frame that is then delivered to the native valve's annulus.
Development of prostheses including but not limited to replacement heart valves that can be compacted for delivery and then controllably expanded for controlled placement has proven to be particularly challenging. An additional challenge relates to the ability of such prostheses to be secured relative to intralumenal tissue, e.g., tissue within any body lumen or cavity, in an atraumatic manner. These replacement valves are often intended to at least partially block blood flow. However, a problem occurs when blood flows around the valve on the outside of the prosthesis. For example, in the context of replacement heart valves, paravalvular leakage has proven particularly challenging.
Embodiments of the present disclosure are directed to a prosthesis, such as but not limited to a replacement heart valve. In some embodiments a prosthesis can comprise an expandable frame, a plurality of distal anchors and a plurality of proximal anchors. The anchors can extend outwardly from the frame. The frame can be configured to radially expand and contract for deployment within the body cavity. When the frame is in an expanded configuration, the proximal anchors can extend a significant distance away from the exterior of the frame, such as a length of about one-half or more the diameter of the frame. In some embodiments, at least some of the anchors comprise a loop that forms an atraumatic end of a corresponding anchor. In some embodiments, an outer skirt may be positioned annularly around an exterior of the expandable frame and be connected to some of the anchors to create an axial barrier to fluid flow exterior to the frame when deployed within the body cavity.
Further embodiments are directed to methods of delivering a prosthesis, e.g. a replacement heart valve, methods of securing a prosthesis to intralumenal tissue, and methods of using a prosthesis to create a barrier to fluid flow exterior to the prosthesis (e.g., to prevent paravalvular leakage).
In some embodiments, a prosthesis can be configured to grasp intralumenal tissue when deployed within a body cavity. The prosthesis can comprise an expandable frame, a plurality of proximal anchors connected to the frame, and a plurality of distal anchors connected to the frame. The expandable frame can comprise a proximal end and a distal end and a longitudinal axis extending therethrough, the frame configured to collapse radially for delivery and to expand radially upon deployment. The plurality of proximal anchors can be expandable to a configuration wherein a portion of each of the proximal anchors extends generally distally and an end of each of the proximal anchors is positioned radially outward from the frame. The plurality of distal anchors can be expandable to a configuration wherein a portion of each of the distal anchors extends generally proximally and an end of each of the distal anchors is positioned radially outward from the frame. Expansion of the frame from a first at least partially collapsed size to a second expanded size can cause the ends of the proximal anchors and the ends of the distal anchors to draw closer together. At least some of the plurality of proximal anchors can be configured to expand to a radial distance from a central longitudinal axis of the frame that is about 150% or more of a radius of the frame when the frame is in an expanded configuration.
These and other features, aspects and advantages are described below with reference to the drawings, which are intended to illustrate but not to limit the invention. In the drawings, like reference characters denote corresponding features consistently throughout similar embodiments.
The present specification and drawings provide aspects and features of the disclosure in the context of several embodiments of prostheses, replacement heart valves, delivery devices and methods that are configured for use in the vasculature of a patient, such as for replacement of natural heart valves in a patient. These embodiments may be discussed in connection with replacing specific valves such as the patient's aortic or mitral valve. However, it is to be understood that the features and concepts discussed herein can be applied to products other than heart valve implants. For example, the controlled positioning, deployment, and securing features described herein can be applied to medical implants, for example other types of expandable prostheses, for use elsewhere in the body, such as within a vein, or the like. In addition, particular features of a valve, delivery device, etc. should not be taken as limiting, and features of any one embodiment discussed herein can be combined with features of other embodiments as desired and when appropriate.
With initial reference to
The prosthesis can be a replacement heart valve similar to that and including features similar to those disclosed in U.S. Provisional Appl. No. 61/782,707, filed Mar. 14, 2013 and 61/789,783 filed Mar. 15, 2013, U.S. Pat. No. 8,403,983 and U.S. Publication Nos. 2010/0298931, 2011/0313515 and 2012/0078353 the entireties of each of which are hereby incorporated by reference and made a part of this specification. This is inclusive of the entire disclosure and is not in any way limited to the disclosure of the replacement heart valve.
The frame 20 can be made of many different materials, but is preferably made from metal. In some embodiments, the frame 20 can be made from a shape memory material, such as nitinol. A wire frame or a metal tube can be used to make the frame. The wire frame of a metal tube can be cut or etched to remove all but the desired metal skeleton. In some embodiments a metal tube is laser cut in a repeating pattern to form the frame. The flat pattern can be cut from a metal tube and then the tube can be bent and expanded to the shape shown in
As shown, the frame when in an expanded configuration, such as in a fully expanded configuration, has a cylindrical or slightly cylindrical shape, where a middle portion is substantially similar in shape and size as the proximal 32 and distal 34 ends. The frame can be a substantially cylindrical shape with the same or substantially the constant cross-sectional dimension or diameter from the proximal end to the distal end. The cylindrical shape of the frame, in combination with the anchors described below, can advantageously allow the frame to float within a native valve while the anchors engage a native valve annulus or other body cavity and spacing the inlet and outlet of the frame away from the heart or vessel wall. This can help reduce undesired contact between the prosthesis and the heart or vessel, such as the ventricular wall of the heart. The prosthesis 10 and frame 20 may be similar to the replacement heart valves and associated frames disclosed in U.S. Provisional Appl. No. 61/782,707, filed Mar. 14, 2013 and 61/789,783 filed Mar. 15, 2013, U.S. Pat. No. 8,403,983 and U.S. Publication Nos. 2010/0298931 and 2011/0313515 the entireties of each of which are hereby incorporated by reference and made a part of this specification. This is inclusive of the entire disclosure and is not in any way limited to the disclosure of the replacement heart valves and associated frames.
A number of struts collectively make up the frame 20.
Some of the struts can include one or more eyelet 46. As illustrated, a plurality of eyelets, here five, are located along one of the longitudinal struts 12 as part of the sideways diamond-shaped cells. One or more eyelets can be positioned in other locations along the frame and/or anchors. The eyelets 46 may be used to attach features such as the valve 60, outer skirt 30, and/or valve skirt 70 to the frame 20.
The frame 20 as illustrated is foreshortening. The foreshortening can be defined by the frame 20 and the positioning of various types of struts along the frame 20. When the frame is radially collapsed or compacted, the struts 14 become more parallel with respect to the longitudinal axis of the frame, causing cells 16 and 18 to collapse, causing an outer diameter of the frame to decrease and the longitudinal length of the frame to increase. As the frame moves from a compacted position to an expanded position, the cells 16 and 18 widen sideways and the longitudinal length of the frame can decrease. It will be appreciated while in some embodiments the entire length of the frame 20 is foreshortening, in other embodiments such as embodiments of the prostheses described in the patents and applications incorporated by reference herein, only a portion of the frame is foreshortening.
Foreshortening of the frame 20 can be used to engage and secure the prosthesis to intralumenal tissue in a body cavity, for example tissue at or adjacent a native valve, such as a native valve annulus and/or leaflets. Opposing anchors 22, 24 can be constructed on the frame 20 so that portions of the anchors, such as tips or ends 26, 28, move closer together as the frame foreshortens. As one example, this can allow the anchors 22, 24 to grasp tissue on opposite sides of the native mitral annulus to thereby secure the prosthesis at the mitral valve.
The anchors 22, 24 and anchor tips 26, 28 can be located anywhere along the frame 20 just so long as at least one of the anchors is either connected to a foreshortening portion or a foreshortening portion is positioned between the anchors so that a portion of the anchors will be move closer together with expansion of the frame. As shown in
Preferably, each of the anchors 22, 24 is positioned or extends generally radially outwardly from the frame 20 so that the anchor tips 26, 28 are generally spaced away or radially outward from the rest of the frame 20. For example, the anchor tips may be located radially outward from the middle portion of the frame, with the tips 26 and 28 being axially spaced from one another. In some embodiments, all or part of the structure connected to the anchor tip and extending radially from the frame, including one or more rings and/or struts, can be considered part of the anchor. The anchors can include a base located on the anchor on a side opposite the tip. The base can be for example where the anchor begins to extend from or away from the frame 20.
For example, the distal anchors 24 are shown having looped anchors. Each looped anchor has a first base 42 and a second base 44 connected to the frame, wherein the first and second bases are at the distal-most corners of adjacent cells. Alternatively, the first and second bases may be located at adjacent corners of the same cell, or at opposite corners of the same cell if for example the cells adjacent the distal end of the frame have the same configuration as the cells shown in
In addition, as illustrated in
The proximal anchors 22 are shown having looped anchors of a similar shape and configuration as the distal anchors 24. It can be seen that each proximal anchor extends from or near the proximal end of the frame at bases 54 and 56 located on adjacent proximal-most corners of cells 16. In the embodiment illustrated in
In addition, adjacent proximal anchors can share the same base where the anchors are bent outward from the frame, or may be considered to extend from the same corner on cell 16. In other embodiments, proximal anchors can be spaced apart so that there is at least a ½ cell or one cell located between the proximal anchors. It will be understood that the proximal anchors can have other configurations such as described in the applications included in the appendix and that the proximal anchors may not be symmetrical. As illustrated in
In some embodiments, in an expanded state such as shown in
In some embodiments the diameter of the frame 20 may be in the range of 20-40 mm (or about 20 to about 40 mm), more preferably 25-35 mm (or about 25 to about 35 mm) when expanded. The outermost tip diameter may be greater than the frame diameter as described above and may be in the range of 40-60 mm (or about 40 to about 60 mm), and in some embodiments may be about 50 mm when the frame diameter is about 30 mm. In some embodiments the length of the prosthesis, from proximal to distal end, when compressed, is between 20-40 mm (or about 20 to about 40 mm), more preferably 25 to 30 mm (or about 25 to about 30 mm), for example about 29 mm. When expanded, the prosthesis may have a length between 15 to 20 mm (or about 15 to 20 mm), more preferably 17 to 18 mm (or about 17 to about 18 mm).
The distal anchors 24 can be positioned to be not as far radially outward as the proximal anchors, and the tips 28 may be positioned radially inward of the tips 26. As described further below, such a configuration may be advantageous in positioning and securing the prosthesis in a mitral valve or other body location. In some embodiments, as illustrated in
It will be understood that the anchors can have various other configurations. In some embodiments, each of the anchors can extend radially outwardly from the frame at an anchor base and terminate at an anchor tip. The anchors can be connected to the frame at one of many different locations including apices, junctions, other parts of struts, etc. The anchors can comprise first, second, third, or more spaced apart bending stages along the length of each anchor. The anchors can also extend either distally or proximally before and/or after one or more of the bending stages. A portion of the anchor may extend with the frame before or after any bending stages. As shown, the anchors 22, 24 may comprise loops as described above, having a curved or arcuate atraumatic tip to minimize damage to body tissue. Further details that may be incorporated and/or interchanged with the features described herein are disclosed in U.S. Provisional Appl. No. 61/782,707, filed Mar. 14, 2013 and 61/789,783 filed Mar. 15, 2013, U.S. Pat. No. 8,403,983 and U.S. Publication Nos. 2010/0298931, 2011/0313515 and 2012/0078353, incorporated by reference herein.
In one embodiment the prosthesis has nine distal anchors and nine proximal anchors. Any number of proximal and distal anchors may be used. In other embodiments, instead of a 1:1 correspondence between anchors, other ratios, such as a 9:6 or a 9:3 correspondence between the anchors, are possible.
With respect to the number of cells and rows of cells, when there are nine proximal anchors and nine distal anchors, there may be two rows of nine cells 16 each. The cells in the second row can share struts 14 from the first row. A third row at the distal end can have a different cell configuration with sideways diamonds as illustrated in
The anchor tips 26 and 28 as described above advantageously provide atraumatic surfaces that may be used to grasp intralumenal tissue without causing unnecessary or undesired trauma to tissue. For example, the proximal anchors tips 26 and distal anchor tips 28 may form flat, substantially flat, curved or other non-sharp surfaces to allow the tips to engage and/or grasp tissue, without necessarily piercing or puncturing through tissue. A looped end or looped anchor may assist the frame in not getting caught up on structures at or near the treatment location. For example, each loop can be configured so that when the frame is deployed in-situ and the anchors expand away from the frame, the movement of each loop from a delivered position to a deployed position avoids getting caught on the papillary muscles.
The prosthesis 10 may include a valve 60 as can be seen in schematically in
In some embodiments, the leaflets can be coupled to a valve skirt 70. For example,
The valve skirt 70 can be used to at least partially control how fluid flows through and/or around the valve 60. The valve skirt 70 can surround at least a portion of the valve and be connected to the valve leaflets. In some embodiments, the valve skirt 70 can form an inner wall connected to and positioned within the frame 20. For example the skirt 70 can connect to the frame at the eyelets 46, such as by stitching. The skirt may also be attached directing to the struts, typically also by stitching. The valve skirt 70 can also be made to move with the foreshortening portion of the frame 20.
The valve skirt 70 can extend the length of the frame 20 or it can extend along only part of the length of the frame 20. In some embodiments, the ends of the heart valve 60 can coincide with ends of the valve skirt 70. In addition, one or more of the ends of the frame 20 can coincide with the ends of the valve skirt 70. In the illustrated embodiment of
Other shapes and configurations can also be used for the valve 60 and valve skirt 70. In some embodiments, the valve skirt 70 may extend along the length of the leaflets, but is not connected to them. In the illustrated embodiments, the valve skirt 70 is attached to the frame 20 and the leaflets are attached to the valve skirt 70, such as at the seam 62 in
The valve skirt 70 can be constructed in multiple different ways. The valve skirt 70 can be made a layer of resilient material, such as knit polyester or another stretchable or flexible fabric. In some embodiments, the valve skirt 70 is made from a material that is more flexible than the valve leaflet material. The distal and/or proximal end of the skirt 70 can be straight, curved, or have any other desired configuration. For example, the valve skirt 70 is shown with a straight proximal end at the proximal end 32 of the frame. In other embodiments the skirt distal end can be patterned to generally correspond to the undulations at one end of the frame 20. The valve skirt 70 can be formed of one piece or multiple pieces. For example, the valve skirt 70 attached to the valve 60 can be one piece and then each distal anchor can be covered by a separate piece of material of the valve skirt 70. It is to be understood that other configurations of the valve skirt 70 can also be employed. For example, the anchors may remain uncovered, or only a portion may be covered.
In another embodiment of the valve skirt 70, the end can extend past the frame and can be wrapped around it. Thus, the valve skirt 70 can extend from the inside of the frame 20 to the outside of the frame. The skirt can extend completely around the frame for ¼, ⅓, ½, or more of the length of the distal anchors. Such an embodiment is shown and described with respect to
The valve skirt 70, and particularly portions that cover the distal anchors 24, can beneficially be used to help prevent leakage of blood flow around the heart valve. In addition, the skirt can encourage tissue in-growth between the skirt and the natural tissue. This may further help to prevent leakage of blood flow around the heart valve.
Continuing to look to
The outer skirt 30 can attach to the frame, and more preferably attach to the anchors, in one of many different ways. The outer skirt 30 can be sewn to the frame and/or valve skirt. The outer skirt 30 can also be wrapped around a portion of the frame and then sewn to itself. In the embodiment illustrated in
In one embodiment, the outer skirt 30 is only attached to the frame via the proximal anchors, and the first portion 64 remains unattached to any portion of the frame or any anchors. In another embodiment, the outer skirt is both attached to the proximal anchors and to the middle portion of the frame. As illustrated in
In some embodiments, the outer skirt 30 can attach to the frame at a distal end of the skirt, or at some other location and then curve up and out towards the proximal anchors. Thus, the outer skirt may not have a distinct first portion and second portion. In still other embodiments, the outer skirt may extend along a substantial portion of the frame. Additional examples of outer skirt features that may be incorporated and/or interchanged with the features described herein are found in U.S. Provisional Application No. 61/789,783 filed Mar. 15, 2013 incorporated by reference herein.
In
Turning now to
In some embodiments, the outer skirt 30 can be part of, or connected to, the valve skirt 70, such as being connected to the valve skirt 70 at or near the distal end 34 of the frame.
The outer skirt 30 can be constructed in multiple different ways and may be made of similar material to the valve skirt 70. The outer skirt 30 can be made of a layer of resilient material, such as knit polyester or another stretchable or flexible fabric. In some embodiments, the outer skirt 30 is made from a material that is more flexible than the valve leaflet material. The distal and/or proximal end of the outer skirt 30 can be straight, curved, or have any other desired configuration. The outer skirt 30 can be formed of one piece or multiple pieces. For example, the outer skirt 30 attached to the frame 20 can be one piece and then each proximal anchor 22 can be covered by a separate piece of material of the outer skirt 30. It is to be understood that other configurations of the outer skirt 30 can also be employed. For example, the anchors may remain uncovered, or only a portion may be covered.
The outer skirt 30 can beneficially prevent axial flow of fluid around an exterior of the prosthesis. For example, with the outer skirt 30 be positioned annularly around an exterior of the expandable frame and secured to at least some of the plurality of proximal anchors, the outer skirt creates an axial barrier to fluid flow exterior to the frame when deployed within a body cavity. In addition, the skirt can encourage tissue in-growth between the skirt and the natural tissue. This may further help to prevent leakage of blood flow around the heart valve.
In one embodiment, the outer skirt 30 can be used to help prevent leakage of blood flow around a heart valve, such as a mitral valve, when the prosthesis is placed in a native heart valve. For example, the outer skirt 30 can engage an atrial side of the mitral valve. The proximal anchors can also engage the mitral valve forcing the outer skirt 30 into close contact with the valve to block flow from passing through the mitral valve from outside of the frame.
In preferred embodiments, the prostheses 10 in the form of a replacement heart such as described above may be deployed into a heart valve annulus. The prosthesis 10 may be delivered into the mitral valve in a radially compacted or collapsed configuration and positioned when compacted so that the anchor tips 26, 28 of the opposing anchors 22, 24 are disposed on opposite sides of the native annulus 98 as shown in
In one preferred embodiment, a method is provided of delivering a replacement valve to a native mitral valve and atraumatically securing the replacement valve relative to the native mitral valve annulus 98. The replacement valve can be mounted on a delivery device and delivered to the native mitral valve annulus while the replacement valve is in a radially compacted state. The replacement valve may be positioned so that the ends or tips of the distal anchors are on a ventricular side of the native leaflets 90 beyond a location where chordae tendineae 92 connect to free ends of the native leaflets. At least a portion of the replacement valve can be released from the delivery device to thereby expand the distal anchors radially outwardly. At this time the distal anchors may extend between at least some of the chordae. The distal anchors (along with the frame) can be moved toward the ventricular side of the native valve annulus with the distal anchors extending between at least some of the chordae tendineae to provide tension on the chordae tendineae. With tension provided on the chordae tendineae, the replacement valve can be further released from the delivery device to thereby expand the proximal anchors radially outwardly. The proximal anchors upon further release of the replacement valve from the delivery device can move into engagement with tissue on an atrial side of the native valve annulus, such as with the atrial side of the native valve annulus.
The method just described may utilize any of the prostheses herein described, including those described in the patent and applications incorporated by reference. The illustrated prosthesis where the ends of the distal anchors are not positioned as far out radially as the ends of the proximal anchors when the frame is expanded can beneficially be used in this method. Thus, the distal anchors may have a suitable length for extending between and providing tension on the chordae tendineae, but need not and may in some embodiments not engage tissue with the tips 28, such as shown in
As illustrated in
When the prosthesis is in an expanded configuration within the native mitral heart valve, the engagement of the proximal anchors 22 with tissue on the atrial side of the native mitral valve causes at least a portion of the outer skirt 30 to also engage the tissue on the atrial side of the native mitral valve. A portion of the outer skirt extends distally from the proximal anchors toward the ventricle. Because the diameter of the outer skirt decreases to a size of close or the same in dimension as the frame, the outer skirt form a barrier to blood flow around the outside or external to the frame. The outer skirt 30 can be forced against the outside of the frame 20 by the native leaflets. Where the native leaflets do not force the outer skirt 30 against the frame, or where the contact is not as strong, the outer skirt 30 is still present to block, or impede blood flow. It will be understood that having multiple contact points between the native valve and the outer skirt can allow the outer skirt to securely cover areas where there are fewer contacts between the two. As described above, the outer skirt may also promote tissue growth with tissue that it contacts.
In addition, due to the preferred outer dimension of the anchors relative to the diameter or radius of the frame in some embodiments, when the frame is radially expanded such that the proximal and/or distal anchors engage tissue at or around the native mitral valve annulus, the frame may move reciprocally in an axial direction relative to the native mitral valve annulus in a constrained floating manner. The one or more of the anchors 22, 24 can be made to flex to provide this reciprocal movement; for example, around the bends between the segments 50, 56 and the base of the anchors. The frame does not exert a significant amount of radial force to the native mitral valve annulus or adjacent tissues, and the frame is primarily secured with the anchors. When in use, the frame may then move relative to the anchor ends as the heart is beating.
The embodiments described in
Although this invention has been disclosed in the context of certain preferred embodiments and examples, it will be understood by those skilled in the art that the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In addition, while a number of variations of the invention have been shown and described in detail, other modifications, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It is also contemplated that various combinations or sub-combinations of the specific features and aspects of the embodiments may be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the disclosed invention. Thus, it is intended that the scope of the present invention herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
Similarly, this method of disclosure, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment. Thus, the claims following the Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment.
This application claims the benefit of priority to U.S. Provisional Appl. No. 61/782,707, filed Mar. 14, 2013, 61/789,783, filed Mar. 15, 2013, and 61/798,115 filed Mar. 15, 2013. The entire contents of the above applications are hereby incorporated by reference and made a part of this specification. Any and all priority claims identified in the Application Data Sheet, or any correction thereto, are hereby incorporated by reference under 37 CFR 1.57.
Number | Name | Date | Kind |
---|---|---|---|
865203 | Mustonen et al. | Sep 1907 | A |
1306391 | Romanoff | Jun 1919 | A |
3312237 | Mon et al. | Apr 1967 | A |
3657744 | Ersek | Apr 1972 | A |
3671979 | Moulopoulos | Jun 1972 | A |
3739402 | Cooley et al. | Jun 1973 | A |
4056854 | Boretos et al. | Nov 1977 | A |
4079468 | Liotta et al. | Mar 1978 | A |
4204283 | Bellhouse et al. | May 1980 | A |
4222126 | Boretos et al. | Sep 1980 | A |
4265694 | Boretos et al. | May 1981 | A |
4339831 | Johnson | Jul 1982 | A |
4340977 | Brownlee et al. | Jul 1982 | A |
4470157 | Love | Sep 1984 | A |
4477930 | Totten et al. | Oct 1984 | A |
4490859 | Black et al. | Jan 1985 | A |
4553545 | Maass et al. | Nov 1985 | A |
4655771 | Wallsten | Apr 1987 | A |
4733665 | Palmaz | Mar 1988 | A |
4776337 | Palmaz | Oct 1988 | A |
4777951 | Cribier et al. | Oct 1988 | A |
4865600 | Carpentier et al. | Sep 1989 | A |
4908028 | Colon et al. | Mar 1990 | A |
4950227 | Savin et al. | Aug 1990 | A |
4994077 | Dobben | Feb 1991 | A |
5049154 | Quadri | Sep 1991 | A |
5133725 | Quadri | Jul 1992 | A |
5197978 | Hess | Mar 1993 | A |
5282826 | Quadri | Feb 1994 | A |
5326371 | Love et al. | Jul 1994 | A |
5332402 | Teitelbaum | Jul 1994 | A |
5344427 | Cottenceau et al. | Sep 1994 | A |
5370685 | Stevens | Dec 1994 | A |
5397355 | Marin | Mar 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5415667 | Frater | May 1995 | A |
5439446 | Barry | Aug 1995 | A |
5449385 | Religa et al. | Sep 1995 | A |
5474563 | Myler et al. | Dec 1995 | A |
5509930 | Love | Apr 1996 | A |
5545214 | Stevens | Aug 1996 | A |
5554185 | Block et al. | Sep 1996 | A |
5575818 | Pinchuk | Nov 1996 | A |
5607444 | Lam | Mar 1997 | A |
5607469 | Frey | Mar 1997 | A |
5669919 | Sanders et al. | Sep 1997 | A |
5697382 | Love et al. | Dec 1997 | A |
D390957 | Fontaine | Feb 1998 | S |
5713952 | Vanney et al. | Feb 1998 | A |
5725519 | Penner | Mar 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5807398 | Shaknovich | Sep 1998 | A |
5810873 | Morales | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
5855601 | Bessler et al. | Jan 1999 | A |
5868777 | Lam | Feb 1999 | A |
5868782 | Frantzen | Feb 1999 | A |
5876437 | Vanney et al. | Mar 1999 | A |
5879381 | Moriuch et al. | Mar 1999 | A |
5902334 | Dwyer et al. | May 1999 | A |
5935108 | Katoh | Aug 1999 | A |
5954764 | Parodi | Sep 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5992000 | Humphrey et al. | Nov 1999 | A |
6004328 | Solar | Dec 1999 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6042606 | Frantzen | Mar 2000 | A |
6053940 | Wijay | Apr 2000 | A |
6086612 | Jansen | Jul 2000 | A |
6113612 | Swanson et al. | Sep 2000 | A |
6113631 | Jansen | Sep 2000 | A |
6132458 | Staehle et al. | Oct 2000 | A |
6152937 | Peterson et al. | Nov 2000 | A |
6159237 | Alt | Dec 2000 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6168616 | Brown, III | Jan 2001 | B1 |
6251093 | Valley et al. | Jun 2001 | B1 |
6280466 | Kugler et al. | Aug 2001 | B1 |
6306141 | Jervis | Oct 2001 | B1 |
6309416 | Swanson et al. | Oct 2001 | B1 |
6312465 | Griffin et al. | Nov 2001 | B1 |
6336938 | Kavteladze et al. | Jan 2002 | B1 |
6352543 | Cole | Mar 2002 | B1 |
6358277 | Duran | Mar 2002 | B1 |
6409759 | Peredo | Jun 2002 | B1 |
6425916 | Garrison et al. | Jul 2002 | B1 |
6440163 | Swanson et al. | Aug 2002 | B1 |
6440164 | DeMatteo et al. | Aug 2002 | B1 |
6454799 | Schreck | Sep 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6475237 | Drasler et al. | Nov 2002 | B2 |
6482228 | Norred | Nov 2002 | B1 |
6511491 | Grudem et al. | Jan 2003 | B2 |
6517573 | Pollock | Feb 2003 | B1 |
6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
6533812 | Swanson et al. | Mar 2003 | B2 |
6551303 | Van Tassei et al. | Apr 2003 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6602281 | Klein | Aug 2003 | B1 |
6610088 | Gabbay | Aug 2003 | B1 |
6641606 | Ouriel et al. | Nov 2003 | B2 |
6652578 | Bailey et al. | Nov 2003 | B2 |
D484979 | Fontaine | Jan 2004 | S |
6676698 | McGuckin et al. | Jan 2004 | B2 |
6682537 | Ouriel et al. | Jan 2004 | B2 |
6695878 | McGuckin et al. | Feb 2004 | B2 |
6712836 | Berg et al. | Mar 2004 | B1 |
6723123 | Kazatchkov et al. | Apr 2004 | B1 |
6730118 | Spenser et al. | May 2004 | B2 |
6733523 | Shaolian et al. | May 2004 | B2 |
6764505 | Hossainy et al. | Jul 2004 | B1 |
6767362 | Schreck | Jul 2004 | B2 |
6780200 | Jansen | Aug 2004 | B2 |
6790229 | Berreklouw | Sep 2004 | B1 |
6790230 | Beyersdorf et al. | Sep 2004 | B2 |
6814746 | Thompson et al. | Nov 2004 | B2 |
6830584 | Sequin | Dec 2004 | B1 |
6858034 | Hijlkema et al. | Feb 2005 | B1 |
6875231 | Anduiza et al. | Apr 2005 | B2 |
6893460 | Spenser et al. | May 2005 | B2 |
6908477 | McGuckin, Jr. et al. | Jun 2005 | B2 |
6908481 | Cribier | Jun 2005 | B2 |
6926732 | Derus et al. | Aug 2005 | B2 |
6929660 | Ainsworth et al. | Aug 2005 | B1 |
6936058 | Forde et al. | Aug 2005 | B2 |
6960219 | Grudem et al. | Nov 2005 | B2 |
6979350 | Moll et al. | Dec 2005 | B2 |
7014653 | Ouriel et al. | Mar 2006 | B2 |
7018401 | Hyodoh et al. | Mar 2006 | B1 |
7018406 | Seguin et al. | Mar 2006 | B2 |
7025780 | Gabbay | Apr 2006 | B2 |
7044134 | Khairkhahan et al. | May 2006 | B2 |
7044962 | Elliott | May 2006 | B2 |
7044966 | Svanidze et al. | May 2006 | B2 |
7087088 | Berg et al. | Aug 2006 | B2 |
7147660 | Chobotov et al. | Dec 2006 | B2 |
7147661 | Chobotov et al. | Dec 2006 | B2 |
7153322 | Alt | Dec 2006 | B2 |
7186265 | Sharkawy et al. | Mar 2007 | B2 |
7198646 | Figulla et al. | Apr 2007 | B2 |
7201772 | Schwammenthal et al. | Apr 2007 | B2 |
7232449 | Sharkawy et al. | Jun 2007 | B2 |
7252682 | Seguin | Aug 2007 | B2 |
D553747 | Fliedner | Oct 2007 | S |
7276078 | Spenser et al. | Oct 2007 | B2 |
7276084 | Yang et al. | Oct 2007 | B2 |
7328270 | Reents et al. | Feb 2008 | B1 |
7329278 | Seguin et al. | Feb 2008 | B2 |
7374571 | Pease et al. | May 2008 | B2 |
7381219 | Salahieh et al. | Jun 2008 | B2 |
7393360 | Spenser et al. | Jul 2008 | B2 |
7422602 | Grudem et al. | Sep 2008 | B2 |
7425219 | Quadri | Sep 2008 | B2 |
7429269 | Schwammenthal et al. | Sep 2008 | B2 |
7442204 | Schwammenthal et al. | Oct 2008 | B2 |
7445631 | Salahieh et al. | Nov 2008 | B2 |
7462191 | Spenser et al. | Dec 2008 | B2 |
7510575 | Spenser et al. | Mar 2009 | B2 |
7524330 | Berreklouw | Apr 2009 | B2 |
7534261 | Friedman | May 2009 | B2 |
7585321 | Cribier | Sep 2009 | B2 |
7608114 | Levine et al. | Oct 2009 | B2 |
7615072 | Rust et al. | Nov 2009 | B2 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7628805 | Spenser et al. | Dec 2009 | B2 |
7632298 | Hijlkema et al. | Dec 2009 | B2 |
7748389 | Salahieh et al. | Jul 2010 | B2 |
7753949 | Lamphere et al. | Jul 2010 | B2 |
D622387 | Igaki | Aug 2010 | S |
D622388 | Igaki | Aug 2010 | S |
7771463 | Ton et al. | Aug 2010 | B2 |
7771472 | Hedricksen et al. | Aug 2010 | B2 |
7785360 | Freitag | Aug 2010 | B2 |
7803185 | Gabbay | Sep 2010 | B2 |
7806917 | Xiao | Oct 2010 | B2 |
7806919 | Bloom et al. | Oct 2010 | B2 |
7815589 | Meade et al. | Oct 2010 | B2 |
7815673 | Bloom et al. | Oct 2010 | B2 |
7824443 | Salahieh et al. | Nov 2010 | B2 |
7846203 | Cribier | Dec 2010 | B2 |
7871435 | Carpentier | Jan 2011 | B2 |
7892281 | Seguin et al. | Feb 2011 | B2 |
D635261 | Rossi | Mar 2011 | S |
D635262 | Rossi | Mar 2011 | S |
7914569 | Nguyen et al. | Mar 2011 | B2 |
7947075 | Goetz et al. | May 2011 | B2 |
7959672 | Salahieh et al. | Jun 2011 | B2 |
7972377 | Lane | Jul 2011 | B2 |
7972378 | Tabor et al. | Jul 2011 | B2 |
7981151 | Rowe | Jul 2011 | B2 |
7993392 | Righini et al. | Aug 2011 | B2 |
7993394 | Hariton et al. | Aug 2011 | B2 |
8016870 | Chew et al. | Sep 2011 | B2 |
8016877 | Seguin et al. | Sep 2011 | B2 |
8048153 | Salahieh et al. | Nov 2011 | B2 |
8052750 | Tuval et al. | Nov 2011 | B2 |
8070800 | Lock et al. | Dec 2011 | B2 |
8070802 | Lamphere et al. | Dec 2011 | B2 |
8075615 | Eberhardt et al. | Dec 2011 | B2 |
8080054 | Rowe | Dec 2011 | B2 |
8092520 | Quadri | Jan 2012 | B2 |
8109996 | Stacchino | Feb 2012 | B2 |
8136218 | Millwee et al. | Mar 2012 | B2 |
8137398 | Tuval et al. | Mar 2012 | B2 |
8157852 | Bloom et al. | Apr 2012 | B2 |
8167926 | Hartley et al. | May 2012 | B2 |
8167932 | Bourang et al. | May 2012 | B2 |
8167934 | Styrc et al. | May 2012 | B2 |
8177799 | Orban, III | May 2012 | B2 |
8182528 | Salahieh et al. | May 2012 | B2 |
8182530 | Huber | May 2012 | B2 |
8216261 | Solem | Jul 2012 | B2 |
8216301 | Bonhoeffer et al. | Jul 2012 | B2 |
8219229 | Cao et al. | Jul 2012 | B2 |
8220121 | Hendriksen et al. | Jul 2012 | B2 |
8221482 | Cottone et al. | Jul 2012 | B2 |
8221493 | Boyle et al. | Jul 2012 | B2 |
8226710 | Nguyen et al. | Jul 2012 | B2 |
D665079 | Zago | Aug 2012 | S |
D665080 | Zago | Aug 2012 | S |
8236045 | Benichou et al. | Aug 2012 | B2 |
8246675 | Zegdi | Aug 2012 | B2 |
8246678 | Salahieh et al. | Aug 2012 | B2 |
8252051 | Chau et al. | Aug 2012 | B2 |
8252052 | Salahieh et al. | Aug 2012 | B2 |
8287584 | Salahieh et al. | Oct 2012 | B2 |
8303653 | Bonhoeffer et al. | Nov 2012 | B2 |
8313525 | Tuval et al. | Nov 2012 | B2 |
8317854 | Ryan et al. | Nov 2012 | B1 |
8323335 | Rowe et al. | Dec 2012 | B2 |
8337541 | Quadri et al. | Dec 2012 | B2 |
8353953 | Giannetti et al. | Jan 2013 | B2 |
8361137 | Perouse | Jan 2013 | B2 |
8361537 | Shanley | Jan 2013 | B2 |
8398708 | Meiri et al. | Mar 2013 | B2 |
8403983 | Quadri et al. | Mar 2013 | B2 |
8408214 | Spenser | Apr 2013 | B2 |
8414644 | Quadri et al. | Apr 2013 | B2 |
8414645 | Dwork et al. | Apr 2013 | B2 |
8444689 | Zhang | May 2013 | B2 |
8449466 | Duhay et al. | May 2013 | B2 |
8449599 | Chau et al. | May 2013 | B2 |
8449625 | Campbell et al. | May 2013 | B2 |
8454685 | Hariton et al. | Jun 2013 | B2 |
8470023 | Eidenschink et al. | Jun 2013 | B2 |
8470024 | Ghione et al. | Jun 2013 | B2 |
8475521 | Suri et al. | Jul 2013 | B2 |
8475523 | Duffy | Jul 2013 | B2 |
8479380 | Malewicz et al. | Jul 2013 | B2 |
8491650 | Wiemeyer et al. | Jul 2013 | B2 |
8500798 | Rowe et al. | Aug 2013 | B2 |
8511244 | Holecek et al. | Aug 2013 | B2 |
8512401 | Murray, III et al. | Aug 2013 | B2 |
8518106 | Duffy et al. | Aug 2013 | B2 |
8535368 | Headley, Jr. et al. | Sep 2013 | B2 |
8562663 | Mearns et al. | Oct 2013 | B2 |
8579964 | Lane et al. | Nov 2013 | B2 |
8579965 | Bonhoeffer et al. | Nov 2013 | B2 |
8584849 | McCaffrey | Nov 2013 | B2 |
8585749 | Shelso | Nov 2013 | B2 |
8585755 | Chau et al. | Nov 2013 | B2 |
8585756 | Bonhoeffer et al. | Nov 2013 | B2 |
8591570 | Revuelta et al. | Nov 2013 | B2 |
8597348 | Rowe et al. | Dec 2013 | B2 |
8617236 | Paul et al. | Dec 2013 | B2 |
8623075 | Murray, III et al. | Jan 2014 | B2 |
8640521 | Righini et al. | Feb 2014 | B2 |
8647381 | Essinger et al. | Feb 2014 | B2 |
8652145 | Maimon et al. | Feb 2014 | B2 |
8652201 | Oberti et al. | Feb 2014 | B2 |
8652202 | Alon et al. | Feb 2014 | B2 |
8652203 | Quadri et al. | Feb 2014 | B2 |
8668730 | McGuckin, Jr. et al. | Mar 2014 | B2 |
8668733 | Haug et al. | Mar 2014 | B2 |
8672992 | Orr | Mar 2014 | B2 |
8673000 | Tabor et al. | Mar 2014 | B2 |
8679174 | Ottma et al. | Mar 2014 | B2 |
8679404 | Liburd et al. | Mar 2014 | B2 |
8685086 | Navia et al. | Apr 2014 | B2 |
8707957 | Callister et al. | Apr 2014 | B2 |
8721707 | Boucher et al. | May 2014 | B2 |
8721708 | Sequin et al. | May 2014 | B2 |
8721714 | Kelley | May 2014 | B2 |
8728154 | Alkhatib | May 2014 | B2 |
8728155 | Montorfano et al. | May 2014 | B2 |
8740974 | Lambrecht et al. | Jun 2014 | B2 |
8740976 | Tran et al. | Jun 2014 | B2 |
8747458 | Tuval et al. | Jun 2014 | B2 |
8747459 | Nguyen et al. | Jun 2014 | B2 |
8747460 | Tuval et al. | Jun 2014 | B2 |
8753384 | Leanna | Jun 2014 | B2 |
8758432 | Solem | Jun 2014 | B2 |
8764814 | Solem | Jul 2014 | B2 |
8764818 | Gregg | Jul 2014 | B2 |
8771344 | Tran et al. | Jul 2014 | B2 |
8771345 | Tuval et al. | Jul 2014 | B2 |
8771346 | Tuval et al. | Jul 2014 | B2 |
8777975 | Kashkarov et al. | Jul 2014 | B2 |
8778020 | Gregg et al. | Jul 2014 | B2 |
8784478 | Tuval et al. | Jul 2014 | B2 |
8784481 | Alkhatib et al. | Jul 2014 | B2 |
8790387 | Nguyen et al. | Jul 2014 | B2 |
8795356 | Quadri et al. | Aug 2014 | B2 |
8795357 | Yohanan et al. | Aug 2014 | B2 |
8828078 | Salahieh et al. | Sep 2014 | B2 |
8828079 | Thielen et al. | Sep 2014 | B2 |
8834564 | Tuval et al. | Sep 2014 | B2 |
8845718 | Tuval et al. | Sep 2014 | B2 |
8852267 | Cattaneo | Oct 2014 | B2 |
8870947 | Shaw | Oct 2014 | B2 |
8870948 | Erzberger et al. | Oct 2014 | B1 |
8876883 | Rust | Nov 2014 | B2 |
8876893 | Dwork et al. | Nov 2014 | B2 |
8876895 | Tuval et al. | Nov 2014 | B2 |
8894702 | Quadri et al. | Nov 2014 | B2 |
8911455 | Quadri et al. | Dec 2014 | B2 |
8926693 | Duffy et al. | Jan 2015 | B2 |
8926694 | Costello | Jan 2015 | B2 |
8945209 | Bonyuet et al. | Feb 2015 | B2 |
8951299 | Paul et al. | Feb 2015 | B2 |
8961583 | Hojeibane et al. | Feb 2015 | B2 |
8961593 | Bonhoeffer et al. | Feb 2015 | B2 |
8961595 | Alkhatib | Feb 2015 | B2 |
8974524 | Yeung et al. | Mar 2015 | B2 |
8979922 | Jayasinghe et al. | Mar 2015 | B2 |
8986375 | Garde et al. | Mar 2015 | B2 |
8992608 | Haug et al. | Mar 2015 | B2 |
8998979 | Seguin et al. | Apr 2015 | B2 |
8998980 | Shipley et al. | Apr 2015 | B2 |
9005270 | Perkins et al. | Apr 2015 | B2 |
9005273 | Salahieh et al. | Apr 2015 | B2 |
9011521 | Haug et al. | Apr 2015 | B2 |
9011523 | Seguin | Apr 2015 | B2 |
9011524 | Eberhardt | Apr 2015 | B2 |
9023100 | Quadri et al. | May 2015 | B2 |
9028545 | Taylor | May 2015 | B2 |
9029418 | Dove et al. | May 2015 | B2 |
9034032 | McLean et al. | May 2015 | B2 |
9034033 | McLean et al. | May 2015 | B2 |
9039757 | McLean et al. | May 2015 | B2 |
9055937 | Rowe et al. | Jun 2015 | B2 |
9078749 | Lutter et al. | Jul 2015 | B2 |
9078751 | Naor | Jul 2015 | B2 |
9125738 | Figulla et al. | Sep 2015 | B2 |
9138312 | Tuval et al. | Sep 2015 | B2 |
9161834 | Taylor et al. | Oct 2015 | B2 |
20010007956 | Letac et al. | Jul 2001 | A1 |
20010021872 | Bailey et al. | Sep 2001 | A1 |
20010047180 | Grudem et al. | Nov 2001 | A1 |
20010047200 | White | Nov 2001 | A1 |
20020016623 | Kula et al. | Feb 2002 | A1 |
20020022853 | Swanson et al. | Feb 2002 | A1 |
20020032481 | Gabbay | Mar 2002 | A1 |
20020045929 | Diaz | Apr 2002 | A1 |
20020052644 | Shaolian et al. | May 2002 | A1 |
20020055772 | McGuckin et al. | May 2002 | A1 |
20020077695 | Swanson et al. | Jun 2002 | A1 |
20020111619 | Keast et al. | Aug 2002 | A1 |
20020111647 | Khairkhahan et al. | Aug 2002 | A1 |
20020183827 | Derus et al. | Dec 2002 | A1 |
20030014104 | Cribier | Jan 2003 | A1 |
20030040792 | Gabbay | Feb 2003 | A1 |
20030083679 | Grudem et al. | May 2003 | A1 |
20030105517 | White et al. | Jun 2003 | A1 |
20030109924 | Cribier | Jun 2003 | A1 |
20030114913 | Spenser et al. | Jun 2003 | A1 |
20030120263 | Ouriel et al. | Jun 2003 | A1 |
20030120330 | Ouriel et al. | Jun 2003 | A1 |
20030120333 | Ouriel et al. | Jun 2003 | A1 |
20030130729 | Paniagua | Jul 2003 | A1 |
20030176914 | Rabkin et al. | Sep 2003 | A1 |
20030187499 | Swanson et al. | Oct 2003 | A1 |
20030199971 | Tower et al. | Oct 2003 | A1 |
20030220683 | Minasian et al. | Nov 2003 | A1 |
20040039436 | Spenser et al. | Feb 2004 | A1 |
20040087900 | Thompson et al. | May 2004 | A1 |
20040093058 | Cottone et al. | May 2004 | A1 |
20040093060 | Seguin et al. | May 2004 | A1 |
20040102842 | Jansen | May 2004 | A1 |
20040117009 | Cali et al. | Jun 2004 | A1 |
20040133273 | Cox | Jul 2004 | A1 |
20040186561 | McGuckin, Jr. et al. | Sep 2004 | A1 |
20040193261 | Berreklou | Sep 2004 | A1 |
20040210304 | Seguin et al. | Oct 2004 | A1 |
20040210307 | Khairkhahan | Oct 2004 | A1 |
20040215325 | Penn et al. | Oct 2004 | A1 |
20040225353 | McGuckin, Jr. et al. | Nov 2004 | A1 |
20040236411 | Sarac et al. | Nov 2004 | A1 |
20040243230 | Navia et al. | Dec 2004 | A1 |
20040249433 | Freitag | Dec 2004 | A1 |
20050033398 | Seguin | Feb 2005 | A1 |
20050038470 | van der Burg et al. | Feb 2005 | A1 |
20050075727 | Wheatley | Apr 2005 | A1 |
20050090887 | Pryor | Apr 2005 | A1 |
20050096738 | Cali et al. | May 2005 | A1 |
20050107872 | Mensah et al. | May 2005 | A1 |
20050125020 | Meade et al. | Jun 2005 | A1 |
20050137682 | Justino | Jun 2005 | A1 |
20050137686 | Salahieh et al. | Jun 2005 | A1 |
20050137687 | Salahieh et al. | Jun 2005 | A1 |
20050137690 | Salahieh et al. | Jun 2005 | A1 |
20050137691 | Salahieh et al. | Jun 2005 | A1 |
20050137693 | Haug et al. | Jun 2005 | A1 |
20050137695 | Salahieh et al. | Jun 2005 | A1 |
20050137701 | Salahieh et al. | Jun 2005 | A1 |
20050154444 | Quadri | Jul 2005 | A1 |
20050159811 | Lane | Jul 2005 | A1 |
20050182483 | Osborne et al. | Aug 2005 | A1 |
20050182486 | Gabbay | Aug 2005 | A1 |
20050203616 | Cribier | Sep 2005 | A1 |
20050203618 | Sharkawy et al. | Sep 2005 | A1 |
20050216079 | Macoviak | Sep 2005 | A1 |
20050234546 | Nugent et al. | Oct 2005 | A1 |
20050240204 | Grudem et al. | Oct 2005 | A1 |
20050251251 | Cribier | Nov 2005 | A1 |
20050283231 | Haug et al. | Dec 2005 | A1 |
20060020247 | Kagan et al. | Jan 2006 | A1 |
20060020327 | Lashinski et al. | Jan 2006 | A1 |
20060020334 | Lashinski et al. | Jan 2006 | A1 |
20060052802 | Sterman et al. | Mar 2006 | A1 |
20060052867 | Revuelta et al. | Mar 2006 | A1 |
20060058872 | Salahieh et al. | Mar 2006 | A1 |
20060095115 | Bladillah et al. | May 2006 | A1 |
20060106454 | Osborne et al. | May 2006 | A1 |
20060116625 | Renati et al. | Jun 2006 | A1 |
20060129235 | Seguin et al. | Jun 2006 | A1 |
20060149360 | Schwammenthal et al. | Jul 2006 | A1 |
20060161265 | Levine et al. | Jul 2006 | A1 |
20060173537 | Yang et al. | Aug 2006 | A1 |
20060195183 | Navia et al. | Aug 2006 | A1 |
20060212110 | Osborne et al. | Sep 2006 | A1 |
20060224232 | Chobotov | Oct 2006 | A1 |
20060241745 | Solem | Oct 2006 | A1 |
20060253191 | Salahieh et al. | Nov 2006 | A1 |
20060259135 | Navia et al. | Nov 2006 | A1 |
20060259136 | Nguyen et al. | Nov 2006 | A1 |
20060265056 | Nguyen et al. | Nov 2006 | A1 |
20060287717 | Rowe et al. | Dec 2006 | A1 |
20060287719 | Rowe et al. | Dec 2006 | A1 |
20060293745 | Carpentier et al. | Dec 2006 | A1 |
20070010876 | Salahieh et al. | Jan 2007 | A1 |
20070016286 | Hermann et al. | Jan 2007 | A1 |
20070043435 | Seguin et al. | Feb 2007 | A1 |
20070050021 | Johnson | Mar 2007 | A1 |
20070067016 | Jung | Mar 2007 | A1 |
20070100432 | Case et al. | May 2007 | A1 |
20070118206 | Colgan et al. | May 2007 | A1 |
20070118207 | Amplatz et al. | May 2007 | A1 |
20070123798 | Rahamimov | May 2007 | A1 |
20070129794 | Realyvasquez | Jun 2007 | A1 |
20070142906 | Figulla et al. | Jun 2007 | A1 |
20070162107 | Haug et al. | Jul 2007 | A1 |
20070185559 | Shelso | Aug 2007 | A1 |
20070213813 | Von Segesser et al. | Sep 2007 | A1 |
20070219620 | Eells et al. | Sep 2007 | A1 |
20070233228 | Eberhardt et al. | Oct 2007 | A1 |
20070250151 | Pereira | Oct 2007 | A1 |
20070255391 | Hojeibane et al. | Nov 2007 | A1 |
20070255394 | Ryan | Nov 2007 | A1 |
20070270932 | Headley et al. | Nov 2007 | A1 |
20070270937 | Leanna | Nov 2007 | A1 |
20070293940 | Schaeffer et al. | Dec 2007 | A1 |
20080009934 | Schneider et al. | Jan 2008 | A1 |
20080021546 | Patz et al. | Jan 2008 | A1 |
20080071361 | Tuval et al. | Mar 2008 | A1 |
20080071363 | Tuval et al. | Mar 2008 | A1 |
20080071366 | Tuval et al. | Mar 2008 | A1 |
20080071369 | Tuval et al. | Mar 2008 | A1 |
20080082164 | Friedman | Apr 2008 | A1 |
20080082165 | Wilson et al. | Apr 2008 | A1 |
20080082166 | Styrc et al. | Apr 2008 | A1 |
20080097571 | Denison et al. | Apr 2008 | A1 |
20080097581 | Shanley | Apr 2008 | A1 |
20080114441 | Rust et al. | May 2008 | A1 |
20080125853 | Boyle et al. | May 2008 | A1 |
20080125859 | Salahieh et al. | May 2008 | A1 |
20080133003 | Seguin | Jun 2008 | A1 |
20080140189 | Nguyen et al. | Jun 2008 | A1 |
20080147179 | Cai et al. | Jun 2008 | A1 |
20080147183 | Styrc | Jun 2008 | A1 |
20080161911 | Revuelta et al. | Jul 2008 | A1 |
20080177381 | Navia et al. | Jul 2008 | A1 |
20080183273 | Mesana et al. | Jul 2008 | A1 |
20080208307 | Ben-Muvhar et al. | Aug 2008 | A1 |
20080208328 | Antocci et al. | Aug 2008 | A1 |
20080208332 | Lamphere et al. | Aug 2008 | A1 |
20080221672 | Lamphere et al. | Sep 2008 | A1 |
20080228254 | Ryan | Sep 2008 | A1 |
20080243233 | Ben-Muvhar et al. | Oct 2008 | A1 |
20080243245 | Thambar et al. | Oct 2008 | A1 |
20080262596 | Xiao | Oct 2008 | A1 |
20080269878 | Iobbi | Oct 2008 | A1 |
20080275549 | Rowe | Nov 2008 | A1 |
20080275550 | Kheradvar et al. | Nov 2008 | A1 |
20090005863 | Goetz et al. | Jan 2009 | A1 |
20090012602 | Quadri | Jan 2009 | A1 |
20090054976 | Tuval et al. | Feb 2009 | A1 |
20090062908 | Bonhoeffer et al. | Mar 2009 | A1 |
20090076585 | Hendriksen | Mar 2009 | A1 |
20090076598 | Salahieh et al. | Mar 2009 | A1 |
20090082844 | Zacharias et al. | Mar 2009 | A1 |
20090082847 | Zacharias et al. | Mar 2009 | A1 |
20090088832 | Chew et al. | Apr 2009 | A1 |
20090088836 | Bishop et al. | Apr 2009 | A1 |
20090099643 | Hyodoh et al. | Apr 2009 | A1 |
20090099653 | Suri et al. | Apr 2009 | A1 |
20090125096 | Chu et al. | May 2009 | A1 |
20090125104 | Hoffman | May 2009 | A1 |
20090132035 | Roth et al. | May 2009 | A1 |
20090132037 | Hoffman et al. | May 2009 | A1 |
20090138069 | Hoffman | May 2009 | A1 |
20090138079 | Tuval et al. | May 2009 | A1 |
20090149946 | Dixon | Jun 2009 | A1 |
20090157175 | Benichou | Jun 2009 | A1 |
20090163934 | Raschdorf et al. | Jun 2009 | A1 |
20090171438 | Chuter et al. | Jul 2009 | A1 |
20090171456 | Kveen et al. | Jul 2009 | A1 |
20090177262 | Oberti et al. | Jul 2009 | A1 |
20090182407 | Leanna et al. | Jul 2009 | A1 |
20090182413 | Burkart et al. | Jul 2009 | A1 |
20090188964 | Orlov | Jul 2009 | A1 |
20090192601 | Rafiee et al. | Jul 2009 | A1 |
20090216314 | Quadri | Aug 2009 | A1 |
20090234443 | Ottma et al. | Sep 2009 | A1 |
20090248132 | Bloom et al. | Oct 2009 | A1 |
20090248133 | Bloom et al. | Oct 2009 | A1 |
20090264997 | Salahieh et al. | Oct 2009 | A1 |
20090270972 | Lane | Oct 2009 | A1 |
20090276040 | Rowe et al. | Nov 2009 | A1 |
20090281618 | Hill et al. | Nov 2009 | A1 |
20090281619 | Le et al. | Nov 2009 | A1 |
20090287296 | Manasse | Nov 2009 | A1 |
20090287299 | Tabor et al. | Nov 2009 | A1 |
20090292350 | Eberhardt et al. | Nov 2009 | A1 |
20090306768 | Quadri | Dec 2009 | A1 |
20100004740 | Sequin et al. | Jan 2010 | A1 |
20100036479 | Hill et al. | Feb 2010 | A1 |
20100049306 | House et al. | Feb 2010 | A1 |
20100082089 | Quadri et al. | Apr 2010 | A1 |
20100082094 | Quadri et al. | Apr 2010 | A1 |
20100094411 | Tuval et al. | Apr 2010 | A1 |
20100114299 | Ben Muvhar et al. | May 2010 | A1 |
20100114305 | Kang et al. | May 2010 | A1 |
20100121461 | Sobrino-Serrano et al. | May 2010 | A1 |
20100161027 | Orr | Jun 2010 | A1 |
20100179633 | Solem | Jul 2010 | A1 |
20100179647 | Carpenter et al. | Jul 2010 | A1 |
20100191326 | Alkhatib | Jul 2010 | A1 |
20100217382 | Chau et al. | Aug 2010 | A1 |
20100249894 | Oba et al. | Sep 2010 | A1 |
20100249911 | Alkhatib | Sep 2010 | A1 |
20100256723 | Murray | Oct 2010 | A1 |
20100262157 | Silver et al. | Oct 2010 | A1 |
20100274345 | Rust | Oct 2010 | A1 |
20100280606 | Naor | Nov 2010 | A1 |
20100298931 | Quadri et al. | Nov 2010 | A1 |
20100305685 | Millwee et al. | Dec 2010 | A1 |
20100312333 | Navia et al. | Dec 2010 | A1 |
20110004296 | Lutter et al. | Jan 2011 | A1 |
20110022157 | Essinger et al. | Jan 2011 | A1 |
20110022164 | Quinn et al. | Jan 2011 | A1 |
20110022165 | Oba et al. | Jan 2011 | A1 |
20110022166 | Dahlgren et al. | Jan 2011 | A1 |
20110022169 | Ryan et al. | Jan 2011 | A1 |
20110029067 | McGuckin, Jr. et al. | Feb 2011 | A1 |
20110137397 | Chau et al. | Jun 2011 | A1 |
20110166644 | Keeble et al. | Jul 2011 | A1 |
20110178597 | Navia et al. | Jul 2011 | A9 |
20110208297 | Tuval et al. | Aug 2011 | A1 |
20110208298 | Tuval et al. | Aug 2011 | A1 |
20110218619 | Benichou et al. | Sep 2011 | A1 |
20110224780 | Tabor et al. | Sep 2011 | A1 |
20110224785 | Hacohen | Sep 2011 | A1 |
20110264196 | Savage et al. | Oct 2011 | A1 |
20110313515 | Quadri et al. | Dec 2011 | A1 |
20110319989 | Lane et al. | Dec 2011 | A1 |
20120016411 | Tuval | Jan 2012 | A1 |
20120022639 | Hacohen et al. | Jan 2012 | A1 |
20120022640 | Gross et al. | Jan 2012 | A1 |
20120041550 | Salahieh et al. | Feb 2012 | A1 |
20120059452 | Boucher et al. | Mar 2012 | A1 |
20120059454 | Millwee et al. | Mar 2012 | A1 |
20120078353 | Quadri et al. | Mar 2012 | A1 |
20120078360 | Rafiee | Mar 2012 | A1 |
20120101571 | Thambar et al. | Apr 2012 | A1 |
20120101572 | Kovalsky et al. | Apr 2012 | A1 |
20120123529 | Levi et al. | May 2012 | A1 |
20120179239 | Quadri et al. | Jul 2012 | A1 |
20120215303 | Quadri et al. | Aug 2012 | A1 |
20120259405 | Weber et al. | Oct 2012 | A1 |
20120271398 | Essinger et al. | Oct 2012 | A1 |
20120283824 | Lutter et al. | Nov 2012 | A1 |
20120290062 | McNamara et al. | Nov 2012 | A1 |
20120296418 | Bonyuet et al. | Nov 2012 | A1 |
20120303116 | Gorman, III | Nov 2012 | A1 |
20120310328 | Olson et al. | Dec 2012 | A1 |
20120323316 | Chau et al. | Dec 2012 | A1 |
20130006294 | Kashkarov | Jan 2013 | A1 |
20130018458 | Yohanan et al. | Jan 2013 | A1 |
20130053950 | Rowe et al. | Feb 2013 | A1 |
20130110227 | Quadri et al. | May 2013 | A1 |
20130131788 | Quadri et al. | May 2013 | A1 |
20130131793 | Quadri et al. | May 2013 | A1 |
20130138203 | Quadri et al. | May 2013 | A1 |
20130138207 | Quadri et al. | May 2013 | A1 |
20130144375 | Giasolli et al. | Jun 2013 | A1 |
20130144378 | Quadri et al. | Jun 2013 | A1 |
20130144380 | Quadri et al. | Jun 2013 | A1 |
20130144381 | Quadri et al. | Jun 2013 | A1 |
20130150956 | Yohanan et al. | Jun 2013 | A1 |
20130172983 | Clerc et al. | Jul 2013 | A1 |
20130184811 | Rowe et al. | Jul 2013 | A1 |
20130184813 | Quadri et al. | Jul 2013 | A1 |
20130190861 | Chau et al. | Jul 2013 | A1 |
20130211508 | Lane | Aug 2013 | A1 |
20130253635 | Straubinger et al. | Sep 2013 | A1 |
20130253642 | Brecker | Sep 2013 | A1 |
20130261737 | Costello | Oct 2013 | A1 |
20130304200 | McLean et al. | Nov 2013 | A1 |
20130310928 | Morriss | Nov 2013 | A1 |
20130345786 | Behan | Dec 2013 | A1 |
20140005764 | Schroeder | Jan 2014 | A1 |
20140018912 | Delaloye et al. | Jan 2014 | A1 |
20140039611 | Lane et al. | Feb 2014 | A1 |
20140046427 | Michalak | Feb 2014 | A1 |
20140052237 | Lane et al. | Feb 2014 | A1 |
20140052242 | Revuelta et al. | Feb 2014 | A1 |
20140067054 | Chau et al. | Mar 2014 | A1 |
20140088685 | Yevzlin et al. | Mar 2014 | A1 |
20140100651 | Kheradvar et al. | Apr 2014 | A1 |
20140100653 | Savage et al. | Apr 2014 | A1 |
20140142694 | Tabor et al. | May 2014 | A1 |
20140155990 | Nyuli et al. | Jun 2014 | A1 |
20140163668 | Rafiee | Jun 2014 | A1 |
20140172083 | Bruchman et al. | Jun 2014 | A1 |
20140172085 | Quadri et al. | Jun 2014 | A1 |
20140172086 | Quadri et al. | Jun 2014 | A1 |
20140194981 | Menk et al. | Jul 2014 | A1 |
20140194983 | Kovalsky et al. | Jul 2014 | A1 |
20140214153 | Ottma et al. | Jul 2014 | A1 |
20140214154 | Nguyen et al. | Jul 2014 | A1 |
20140214155 | Kelley | Jul 2014 | A1 |
20140214159 | Vidlund et al. | Jul 2014 | A1 |
20140214160 | Naor | Jul 2014 | A1 |
20140222136 | Geist et al. | Aug 2014 | A1 |
20140222139 | Nguyen et al. | Aug 2014 | A1 |
20140222142 | Kovalsky et al. | Aug 2014 | A1 |
20140236288 | Lambrecht et al. | Aug 2014 | A1 |
20140243966 | Garde et al. | Aug 2014 | A1 |
20140257467 | Lane et al. | Sep 2014 | A1 |
20140257476 | Montorfano et al. | Sep 2014 | A1 |
20140277390 | Ratz et al. | Sep 2014 | A1 |
20140277402 | Essinger et al. | Sep 2014 | A1 |
20140277422 | Ratz et al. | Sep 2014 | A1 |
20140277423 | Alkhatib et al. | Sep 2014 | A1 |
20140277427 | Ratz et al. | Sep 2014 | A1 |
20140296973 | Bergheim et al. | Oct 2014 | A1 |
20140296975 | Tegels et al. | Oct 2014 | A1 |
20140303719 | Cox et al. | Oct 2014 | A1 |
20140309728 | Dehdashtian et al. | Oct 2014 | A1 |
20140309731 | Quadri et al. | Oct 2014 | A1 |
20140309732 | Solem | Oct 2014 | A1 |
20140324160 | Benichou et al. | Oct 2014 | A1 |
20140324164 | Gross et al. | Oct 2014 | A1 |
20140330368 | Gloss et al. | Nov 2014 | A1 |
20140330371 | Gloss et al. | Nov 2014 | A1 |
20140330372 | Weston et al. | Nov 2014 | A1 |
20140331475 | Duffy et al. | Nov 2014 | A1 |
20140336754 | Gurskis et al. | Nov 2014 | A1 |
20140343669 | Lane et al. | Nov 2014 | A1 |
20140343670 | Bakis et al. | Nov 2014 | A1 |
20140343671 | Yohanan et al. | Nov 2014 | A1 |
20140350666 | Righini | Nov 2014 | A1 |
20140350668 | Delaloye et al. | Nov 2014 | A1 |
20140358221 | Ho et al. | Dec 2014 | A1 |
20140364939 | Deshmukh et al. | Dec 2014 | A1 |
20140364943 | Conklin | Dec 2014 | A1 |
20140364944 | Lutter et al. | Dec 2014 | A1 |
20140371842 | Marquez et al. | Dec 2014 | A1 |
20140371845 | Tuval et al. | Dec 2014 | A1 |
20140371847 | Madrid et al. | Dec 2014 | A1 |
20140371848 | Murray, III et al. | Dec 2014 | A1 |
20140379067 | Nguyen et al. | Dec 2014 | A1 |
20140379068 | Thielen et al. | Dec 2014 | A1 |
20140379077 | Tuval et al. | Dec 2014 | A1 |
20150005873 | Chang et al. | Jan 2015 | A1 |
20150012085 | Salahieh et al. | Jan 2015 | A1 |
20150018938 | Von Segesser et al. | Jan 2015 | A1 |
20150018944 | O'Connell et al. | Jan 2015 | A1 |
20150032153 | Quadri et al. | Jan 2015 | A1 |
20150066140 | Quadri | Mar 2015 | A1 |
20150081009 | Quadri | Mar 2015 | A1 |
20150142100 | Morriss | May 2015 | A1 |
20150142103 | Vidlund | May 2015 | A1 |
20150148731 | McNamara et al. | May 2015 | A1 |
20150157458 | Thambar et al. | Jun 2015 | A1 |
20150196390 | Ma et al. | Jul 2015 | A1 |
Number | Date | Country |
---|---|---|
2304325 | Oct 2000 | CA |
2 827 556 | Jul 2012 | CA |
3128704 | Feb 1983 | DE |
10 2006 052 564 | Dec 2007 | DE |
0 657 147 | Jun 1995 | EP |
1 47 996 | Nov 2004 | EP |
1 255 510 | Apr 2007 | EP |
1 772 104 | Apr 2007 | EP |
1 264 471 | Feb 1972 | GB |
1315 844 | May 1973 | GB |
2245495 | Jan 1992 | GB |
2 398 245 | Aug 2004 | GB |
2002-540889 | Dec 2002 | JP |
2008-541865 | Nov 2008 | JP |
WO 9749355 | Dec 1997 | WO |
WO 0053104 | Sep 2000 | WO |
WO 0061034 | Oct 2000 | WO |
WO 0135861 | May 2001 | WO |
WO 0135870 | May 2001 | WO |
WO 0172239 | Oct 2001 | WO |
WO 0236048 | May 2002 | WO |
WO 03092554 | Nov 2003 | WO |
WO 03028522 | Jan 2004 | WO |
WO 2004014257 | Feb 2004 | WO |
WO 2004014474 | Feb 2004 | WO |
WO 2004058097 | Jul 2004 | WO |
WO 2005011534 | Feb 2005 | WO |
WO 2005041810 | May 2005 | WO |
WO 2005087140 | Sep 2005 | WO |
WO 2006070372 | Jul 2006 | WO |
WO 2006085304 | Aug 2006 | WO |
WO 2006089236 | Aug 2006 | WO |
WO 2006127765 | Nov 2006 | WO |
WO 2007025028 | Mar 2007 | WO |
WO 2007034488 | Mar 2007 | WO |
WO 2007058857 | May 2007 | WO |
WO 2007123658 | Nov 2007 | WO |
WO 2007134290 | Nov 2007 | WO |
WO 2008005535 | Jan 2008 | WO |
WO 2008013915 | Jan 2008 | WO |
WO 2008070797 | Jun 2008 | WO |
WO 2008091515 | Jul 2008 | WO |
WO 2008103722 | Aug 2008 | WO |
WO 2008150529 | Dec 2008 | WO |
WO 2009026563 | Feb 2009 | WO |
WO 2009033469 | Mar 2009 | WO |
WO 2009045331 | Apr 2009 | WO |
WO 2009052188 | Apr 2009 | WO |
WO 2009053497 | Apr 2009 | WO |
WO 2009091509 | Jul 2009 | WO |
WO 2009094500 | Jul 2009 | WO |
WO 2009134701 | Nov 2009 | WO |
WO 2009137359 | Nov 2009 | WO |
WO 2009155561 | Dec 2009 | WO |
WO 2010008549 | Jan 2010 | WO |
WO 2010037141 | Apr 2010 | WO |
WO 2010040009 | Apr 2010 | WO |
WO 2010057262 | May 2010 | WO |
WO 2010098857 | Sep 2010 | WO |
WO 2009149462 | Jan 2011 | WO |
WO 2010138853 | Feb 2011 | WO |
WO 2011025945 | Mar 2011 | WO |
WO 2011137531 | Nov 2011 | WO |
WO 2011109801 | Jan 2012 | WO |
WO 2011109813 | Jan 2012 | WO |
WO 2012035279 | Mar 2012 | WO |
WO 2012162228 | Nov 2012 | WO |
WO 2012177942 | Dec 2012 | WO |
WO 2013028387 | Feb 2013 | WO |
WO 2013012801 | Apr 2013 | WO |
WO 2013086413 | Jun 2013 | WO |
Entry |
---|
US 8,062,357, 11/2011, Salahieh et al. (withdrawn) |
U.S. Appl. No. 14/186,989, filed Feb. 21, 2014, Quadri et al. |
U.S. Appl. No. 14/197,639, filed Mar. 5, 2014, Ratz et al. |
U.S. Appl. No. 14/197,690, filed Mar. 5, 2014, Ratz et al. |
U.S. Appl. No. 29,484,001, filed Mar. 5, 2014, Pesce et al. |
CardiAQ Valve Technologies, “Innovations in Heart Valve Therapy,” In3 San Francisco, Jun. 18, 2008, PowerPoint presentation in 19 slides. |
European Extended Search Report, re EP Application No. 14159271.7, dated Jul. 23, 2014. |
European Extended Search Report, re EP Application No. 14159378.0, dated Jul. 24, 2014. |
European Extended Search Report, re EP Application No. 14159090.1, dated Jul. 22, 2014. |
U.S. Appl. No. 61/331,799, filed May 5, 2010, Lane et al. |
U.S. Appl. No. 61/393,860, filed Oct. 15, 2010, Lane et al. |
U.S. Appl. No. 61/414,879, filed Nov. 17, 2010, Lane et al. |
U.S. Appl. No. 14/598,568, filed Jan. 16, 2015, Quadri et al. |
U.S. Appl. No. 14/628,034, filed Feb. 20, 2015, Rabito et al. |
U.S. Appl. No. 14/702,233, filed May 1, 2015, Arshad et al. |
U.S. Appl. No. 14/716,507, filed May 19, 2015, Ratz et al. |
Neovasc Surgical Products, “Neovasc Surgical Products: An Operating Division of Neovasc Inc.,” dated Apr. 2009. |
Kronemyer, Bob: “CardiAQ Valve Technologies: Percutaneous Mitral Valve Replacement,” Start Up—Windhover Review of Emerging Medical Ventures, vol. 14, Issue No. 6, Jun. 2009, pp. 48-49. |
Bavaria, Joseph E. M.D.: “CardiAQ Valve Technologies: Transcatheter Mitral Valve Implantation,” Sep. 21, 2009. |
Ostrovsky, Gene: “Transcatheter Mitral Valve Implantation Technology from CardiAQ,” medGadget, Jan. 15, 2010, available at: http://www.medgadget.com/2010/01/transcatheter—mitral—valve—implantation—technology—from—cardiaq.html. |
“Company Overview,” Jun. 25, 2009 at TVT. |
“Update,” Applicant believes this may have been presented on Jun. 6, 2010 at TVT. |
Banai, Shmuel, et al., Tiara: A Novel Catheter-Based Mitral Valve Bioprosthesis, Initial Experiments and Short-Term Pre-Clinical Results, Journal of the American College of Cardiology, vol. 60, No. 15, 2012. Applicant believes that this may have been available online as early as Sep. 12, 2012. |
Berreklouw, Eric, MD, PhD, et al., “Sutureless Mitral Valve Replacement With Bioprostheses and Nitinol Attachment Rings: Feasibility in Acute Pig Experiments,” The Journal of Thoracic and Cardiovascular Surgery, vol. 142, No. 2, Aug. 2011 in 7 pages, Applicant believes this may have been available online as early as Feb. 4, 2011. |
Boudjemline, Younes, MD, et al., “Steps Toward the Percutaneous Replacement of Atrioventricular Valves,” JACC, vol. 46, No. 2, Jul. 19, 2005:360-5. |
Brinkman, William T., MD, et al., Transcatheter Cardiac Valve Interventions, Surg Clin N Am 89 (2009) 951-966, Applicant believes this may have been available as early as Aug. 2009. |
Chiam, Paul T.L., et al., “Percutaneous Transcatheter Aortic Valve Implantation: Assessing Results, Judging Outcomes, and Planning Trials,” JACC: Cardiovascular Interventions, The American College of Cardiology Foundation, vol. 1, No. 4, Aug. 2008:341-50. |
Condado, Jose Antonio, et al., “Percutaneous Treatment of Heart Valves,” Rev Esp Cardio. 2006;59(12):1225-31, Applicant believes this may have been available as early as Dec. 2006. |
Engager System, Precise Valve Positioning, Transcatheter Aortic Valve Implantation System, Transcatheter Aortic Valve Replacement—TAVR I Medtronic Engager, http://www.medtronic-engager.com/home/transcatheter-aortic-valve-repl., 2014 Medtronic, Inc. in 2 pages. Applicant believes this may have been available online as early as Aug. 25, 2013. |
Fanning, Jonathon P., et al., “Transcatheter Aortic Valve Implantation (TAVI): Valve Design and Evolution,” International Journal of Cardiology 168 (2013) 1822-1831, Applicant believes this may have been available as early as Aug. 20, 2013. |
Fitzgerald, Peter J. M.D., “Tomorrow's Technology: Percutaneous Mitral Valve Replacement, Chordal Shortening, and Beyond,” Transcatheter Valve Therapies (TVT) Conference. Seattle, WA. Applicant believes this may have been available as early as Jun. 7, 2010. |
Gillespie, Matthew J., MD, et al., “Sutureless Mitral Valve Replacement: Initial Steps Toward a Percutaneous Procedure,” Ann Thorac Surg. Aug. 2013; 96(2). |
Grube, Eberhard, MD, et al., “Percutaneous Implantation of the CoreValve Self-Expanding Valve Prosthesis in High-Risk Patients With Aortic Valve Disease, The Siegburg First-in-Man Study” Journal of the American Heart Association, 2006; 114:1616-1624, originally published online Oct. 2, 2006. |
JenaValve Technology, “The JenaValve—The Prosthesis”, 2011 JenaValve Technology in 1 page. |
Karimi, Houshang, MD, et al., “Percutaneous Valve Therapies,” SIS 2007 Yearbook, Chapter 11, pp. 1-11. |
Lauten, Alexander, et al., “Experimental Evaluation of the JenaClip Transcatheter Aortic Valve,” Catheterization and Cardiovascular Interventions 74:514-519, published online May 11, 2009, Applicant believes this may have been available online as early as Apr. 27, 2009. |
Leon, Martin B., MD, et al., “Transcatheter Aortic Valve Replacement in Patients with Critical Aortic Stenosis: Rationale, Device Descriptions, Early Clinical Experiences, and Perspectives,” Semin. Thorac. Cardiovasc. Surg. 18:165-174, 2006 in 10 pages, Applicant believes this may have been available as early as the Summer of 2006. |
Lozonschi, Lucian, MD, et al., “Transapical Mitral Valved Stent Implantation,” Ann Thorac Surg 2008;86:745-8 in 4 pages, Applicant believes this may have been available as early as Sep. 2008. |
Lutter, G., et al.: “Transcatheter Mitral Valve Replacement—Early Animal Results,” Universitätsklinikum, Schleswig-Holstein, unknown publication date. |
Lutter, Georg, et al., “Off-Pump Transapical Mitral Valve Replacement,” European Journal of Cardio-thoracic Surgery 36 (2009) 124-128, Applicant believes this may have been available as early as Apr. 25, 2009. |
Ma, Liang, et al., “Double-Crowned Valved Stents for Off-Pump Mitral Valve Replacement,” European Journal of Cardio-thoracic Surgery 28 (2005) 194-199, Applicant believes this may have been available as early as Aug. 2005. |
Mack, Michael, M.D., “Antegrade Transcatheter Mitral valve Implantation: A Short-term Experience in Swine Model,” Applicant believes this may have been presented on May 2011 at TVT. |
Mack, Michael, M.D., “Antegrade Transcatheter Mitral valve Implantation: On-Going Experience in Swine Model,” Applicant believes this may have been presented on Nov. 2011 at TCT. |
Masson, Jean-Bernard, et al., “Percutaneous Treatment of Mitral Regurgitation,” Circulation: Cardiovascular Interventions, 2:140-146, Applicant believes this may have been available as early as Apr. 14, 2009. |
Ostrovsky, Gene, “A Trial of Zenith Fenestrated AAA Endovascular Graft Goes on,” medGadget, Aug. 1, 2008, available at: :http://www.medgadget.com/2008/08/a—trial—of—zenith—fenestrated—aaa—endovascular—graft—goes—on.html. |
Pluth, James R., M.D., et al., “Aortic and Mitral Valve Replacement with Cloth-Covered Braunwald-Cutter Prosthesis, A Three-Year Follow-up,” The Annals of Thoracic Surgery, vol. 20, No. 3, Sep. 1975, pp. 239-248. |
Quadri, Arshad M.D., “Transcatheter Mitral Valve Implantation (TMVI) (An Acute In Vivo Study),” Applicant believes this may have been presented on Sep. 22, 2010 at TCT. |
Ratz, J. Brent, “In3 Company Overview,” Jun. 24, 2009. |
Ratz, J. Brent, “LSI EMT Spotlight,” May 15, 2009. |
Ruiz, Carlos E., “Overview of Novel Transcatheter Valve Technologies,” Applicant believes this may have been presented on May 27, 2010 at EuroPCR. |
Seidel, Wolfgang, et al., “A Mitral Valve Prosthesis and a Study of Thrombosis on Heart Valves in Dogs,” JSR—vol. II, No. 3—May 1962, submitted for publication Oct. 9, 1961. |
Sondergaard, Lars, et al., “Transcatheter Mitral Valve Implantation: CardiAQ™,” Applicant believes this may have been presented at EuroPCR May 2013. |
Sondergaard, Lars, et al., “Transcatheter Mitral Valve Implantation: CardiAQ™,” Applicant believes this may have been presented at TCT Oct. 2013. |
Spillner, J. et al., “New Sutureless ‘Atrial-Mitral-Valve Prosthesis’ For Minimally Invasive Mitral Valve Therapy,” Textile Research Journal, 2010, in 7 pages, Applicant believes this may have been available as early as Aug. 9, 2010. |
Vu, Duc-Thang, MD, et al., “Novel Sutureless Mitral Valve Implantation Method Involving a Bayonet Insertion and Release Mechanism: A Proof of Concept Study in Pigs,” The Journal of Thoracic and Cardiovascular Surgery, vol. 143, No. 4, 985-988, Apr. 2012, Applicant believes this may have been available online as early as Feb. 11, 2012. |
Walther, Thomas et al., “Transapical Approach for Sutureless Stent-Fixed Aortic Valve Implantation: Experimental Results,” European Journal of Cardio-thoracic Surgery 29 (2006) 703-708, Applicant believes this may have been available as early as May 2006. |
Webb, John G., et al., “Transcatheter Aortic Valve Implantation: The Evolution of Prostheses, Delivery Systems and Approaches,” Archives of Cardiovascular Disease (2012) 105, 153-159, Applicant believes this may have been available as early as Mar. 16, 2012. |
Banai et al.: “Transapical Mitral Implantation of the Tiara Bioprosthesis,” JACC: Cardiovascular Interventions, vol. 7, No. 2, Feb. 2014:154-62. |
Bavaria, Joseph E. M.D. et al.: “Transcatheter Mitral Valve Implantation: The Future Gold Standard for MR?,” Applicant requests the Examiner to consider this reference to be prior art as of Dec. 2010. |
BioSpace, “CardiAQ Valve Technologies (CVT) Reports Cardiovascular Medicine Milestone: First-In-Humannonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve,” Jun. 14, 2012, p. 1, http://www.biospace.com/News/cardiaq-valve-technologies-cvt-reports/263900. |
Businesswire.com, “CardiAQ Valve Technologies (CVT) Discloses Successful Results of Acute In Vivo Study of Its Novel Transcatheter Mitral Valve Implantation (TMVI) System,” Sep. 28, 2009. |
Businesswire.com, CardiAQ Valve Technologies, “CardiAQ Valve Technologies (“CVT”) to disclose data during ‘EuroPCR 2010’ about the world's first successful in vivo transcatheter delivery of a mitral heart valve implant,” Irvine, California, May 20, 2010. |
CardiAQ Valve Technologies Company Fact Sheet 2009. |
Diagnostic and Interventional Cardiology, “Neovasc Announces Publication of Tiara Transcatheter Mitral Valve Preclinical Data in JACC,” Sep. 18, 2012, p. 1, http://www.dicardiology.com/content/neovasc-announces-publication-tiara-transcatheter-mitral-valve-preclinical-data-jacc. |
Diagnostic and Interventional Cardiology, “Neovasc Announces Successful Human Implant of Tiara Transcatheter Mitral Valve,” Feb. 18, 2014, p. 1, <http://www.dicardiology.com/article/neovasc-announces-successful-human-implant-tiara-transcatheter-mitral-valve>. |
Diagnostic and Interventional Cardiology, “Neovasc Receives First U.S. Patent for its Tiara Transcatheter Mitral Valve Replacement Technology,” Nov. 15, 2013, p. 1, <http://www.dicardiology.com/content/neovasc-receives-first-us-patent-its-tiara-transcatheter-mitral- valve-replacement-technology>. |
Feldman, Ted, MD. “Prospects for Percutaneous Valve Therapies,” Circulation 2007;116:2866-2877. Applicant believes that this may be available as early as Dec. 11, 2007. |
Grube, E. et al, “Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.” J Am Coll Cardiol. Jul. 3, 2007;50(1):69-76. Epub Jun. 6, 2007. |
Horvath et al.: “Transapical Aortic Valve Replacement under Real-time Magnetic Resonance Imaging Guidance: Experimental Results with Balloon-Expandable and Self-Expanding Stents,” http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038190/. Jun. 2011. |
Mack, Michael M.D., “Advantages and Limitations of Surgical Mitral Valve Replacement; Lessons for the Transcatheter Approach,” Applicant believes this may have been available as early as Jun. 7, 2010. Applicant believes this may have been presented at the Texas Cardiovascular Innovative Ventures (TCIV) Conference in Dallas, TX on Dec. 8, 2010. |
Neovasc corporate presentation, Oct. 2009, available at http://www.neovasc.com/investors/documents/Neovasc-Corporate-Presentation-October-2009.pdf. |
Piazza, Nicoló, MD, et al., “Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve,” Contemporary Reviews in Interventional Cardiology, Circ. Cardiovasc. Intervent., 2008;1:74-81, Applicant believes this may have been available as early as Aug. 2008. |
Ratz, J. Brent et al., “Any experiences making an expandable stent frame?” Arch-Pub.com, Architecture Forums: Modeling, Multiple forum postings from Feb. 3, 2009 to Feb. 4, 2009, http://www.arch-pub.com. |
Ratz, J. Brent et al., “Fabric, Skin, Cloth expansion . . . best approach?,” AREA by Autodesk, 3ds Max: Modeling, Forum postings from Feb. 18, 2009 to Feb. 19, 2009, http://area.autodesk.com. |
Ratz, J. Brent et al., “Isolating Interpolation,” Arch-Pub.com, Architecture Forums: Animation and Rigging, Forum postings from Feb. 9, 2009 to Feb. 10, 2009, http://www.arch-pub.com. |
Treede et al.: “Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.” http://ejcts.oxfordjournals.org/content/41/6/e131.long. Apr. 16, 2012. |
Van Mieghem, et al., “Anatomy of the Mitral Valvular Complez and Its Implications for Transcatheter Interventions for Mitral Regurgitation,” J. Am. Coll. Cardiol., 56:617-626 (Aug. 17, 2010). |
Wayback Machine, Neovasc Ostial Products Overview, https://web.archive.org/web/20090930050359/https://www.neovasc.com/vascular-products/ostialproducts/default.php, indicated as archived on Sep. 30, 2008. |
Number | Date | Country | |
---|---|---|---|
20140277390 A1 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
61789783 | Mar 2013 | US | |
61782707 | Mar 2013 | US | |
61798115 | Mar 2013 | US |